NCT06995157View on ClinicalTrials.gov

Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

April 1, 2026

Conditions
Cervical Cancer ScreeningVaccination Uptake
Interventions
BIOLOGICAL

Offering HPV vaccine

During regular cervical cancer prevention visit with the gynecologist, HPV vaccine will be offered to participants 35 years or younger.

Trial Locations (1)

1000

RECRUITING

UMC Ljubljana, Ljubljana

Sponsors

Collaborators (1)

MSD Pharmaceuticals LLC
All Listed Sponsors
collaborator

MSD Pharmaceuticals LLC

INDUSTRY

lead

University Medical Centre Ljubljana

OTHER

NCT06995157 - Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination | Biotech Hunter | Biotech Hunter